Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Parkinson's disease is a neurodegenerative disorder which is in most cases of unknown etiology. Mutations of the Park‐2 gene are the most frequent cause of familial parkinsonism and parkin knockout (PK‐KO) mice have abnormalities that resemble the clinical syndrome. We investigated the interaction of genetic and environmental factors, treating midbrain neuronal cultures from PK‐KO and wild‐type (WT) mice with rotenone (ROT). ROT (0.025–0.1 µ m) produced a dose‐dependent selective reduction of tyrosine hydroxylase‐immunoreactive cells and of other neurons, as shown by the immunoreactivity to microtubule‐associated protein 2 in PK‐KO cultures, suggesting that the toxic effect of ROT involved dopamine and other types of neurons. Neuronal death was mainly apoptotic and suppressible by the caspase inhibitor t‐butoxycarbonyl‐Asp(OMe)‐fluoromethyl ketone (Boc‐D‐FMK). PK‐KO cultures were more susceptible to apoptosis induced by low doses of ROT than those from WT. ROT increased the proportion of astroglia and microglia more in PK‐KO than in WT cultures. Indomethacin, a cyclo‐oxygenase inhibitor, worsened the effects of ROT on tyrosine hydroxylase cells, apoptosis and astroglial (glial fibrillary acidic protein) cells. N‐nitro‐l‐arginine methyl ester, an inhibitor of nitric oxide synthase, increased ROT‐induced apoptosis but did not change tyrosine hydroxylase‐immunoreactive or glial fibrillary acidic protein area. Neither indomethacin nor N‐nitro‐l‐arginine methyl ester had any effect on the reduction by ROT of the mitochondrial potential as measured by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide. Microglial NADPH oxidase inhibition, however, protected against ROT. The roles of p38 MAPK and extracellular signal‐regulated kinase signaling pathways were tested by treatment with SB20358 and PD98059, respectively. These compounds were inactive in ROT‐naive cultures but PD98059 slightly increased cellular necrosis, as measured by lactate dehydrogenase levels, caused by ROT, without changing mitochondrial activity. SB20358 increased the mitochondrial failure and lactate dehydrogenase elevation induced by ROT. Minocycline, an inhibitor of microglia, prevented the dropout of tyrosine hydroxylase and apoptosis by ROT; the addition of microglia from PK‐KO to WT neuronal cultures increased the sensitivity of dopaminergic neurons to ROT. PK‐KO mice were more susceptible than WT to ROT and the combined effects of Park‐2 suppression and ROT reproduced the cellular events observed in Parkinson's disease. These events were prevented by minocycline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
The role of glial cells in Parkinsonʼs disease
Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326
Moon, Y., Lee, K. H., Park, J., Geum, D., & Kim, K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03112.x · Cited by 174 · cited 2×
“In vitro, it produces cell apoptosis, caspase 3 activation, change of mitochondrial membrane potential, accumulation and aggregation of alpha-synuclein and ubiquitin, oxidative damage, and endoplasmic reticulum stress (Ryu et al. 2002; Sherer et al. 2002, 2003c; Ahmadi et al. 2003; Tada-Oikawa et al. 2003; Diaz-Corral…”
BackgroundClinical Potential of Minocycline for Neurodegenerative Disorders
BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157
Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Thomas, M., & Le, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453162 · Cited by 114
Cited by
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884
Mitochondrial dysfunction in Parkinson's disease
Bose, A., & Beal, M. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13731 · Cited by 841
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Metadata
- Authors
- Casarejos, M. J., Menéndez, J., Solano, R. M., Rodríguez‐Navarro, J. A., García de Yébenes, J., & Mena, M. A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-03-29
- Volume
- 97
- Issue
- 4
- Pages
- 934-946
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2080929675
- Cited by
- 156
- References
- 8
- FWCI
- 10.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. https://app.cochat.ai/papers/10.1111/j.1471-4159.2006.03777.x
- The paper
- Casarejos, M. J., Menéndez, J., Solano, R. M., Rodríguez‐Navarro, J. A., García de Yébenes, J., & Mena, M. A. (2006). Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2006.03777.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.